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Lawsonia intracellularis associated equine 
proliferative enteropathy in Danish weanling 
foals
Anna Margareta Bohlin1*, Susanne Nautrup Olsen2, Sigrid Hyldahl Laursen2, Anna Öhman1 
and Gaby van Galen2,3
Abstract 
Background: Lawsonia intracellularis, an obligate intracellular bacterium, causes equine proliferative enteropathy, 
mainly in horses around weaning. This disease is rarely reported in the Scandinavian countries.
Results: Five cases of equine proliferative enteropathy were diagnosed between 2008–2016 at the University of 
Copenhagen Large Animal Teaching Hospital. Cases were Danish Warmbloods and a Friesian horse, aged 6–7 months, 
presenting with typical clinical signs of lethargy, poor body condition, pyrexia and diarrhea. Clinical pathology was 
consistent with previous reports of severe hypoalbuminemia and leukocytosis. Diagnosis was confirmed by fecal 
polymerase chain reaction, serum immunomonolayer peroxidase assay and/or immunofluorescence and fluores-
cence in situ hybridization performed on formalin-fixed ileum samples. Concurrent intestinal parasitism was pre-
sent in all five cases. Treatment consisted of antimicrobial therapy, anti-inflammatories, intravenous crystalloids and 
plasma. Three foals were euthanised due to deterioration and poor response to treatment, one with complications of 
septic arthritis and Strongylus vulgaris associated intestinal infarct. The other two foals survived and were reported by 
the owners to be healthy on long-term follow-up.
Conclusions: Equine proliferative enteropathy is a disease to consider in young horses presenting with diarrhea and 
hypoproteinemia in Denmark.
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Background
Lawsonia intracellularis causes equine proliferative 
enteropathy (EPE), mainly in foals around weaning 
[1]. The bacterium is an obligate intracellular curved 
Gram-negative rod [2], and infects enterocytes primar-
ily in the ileum and distal jejunum [3, 4] causing a pro-
liferation of the intestinal mucosal layer and subsequent 
malabsorption.
Typical associated clinical signs are lethargy, anorexia, 
pyrexia, peripheral edema, diarrhea, colic and weight loss 
[1, 4–6]. The most common clinicopathological findings 
include severe hypoalbuminemia and leukocytosis [1, 
7], and abdominal ultrasound typically reveals increased 
small intestinal wall thickness [5, 7, 8]. Fecal polymer-
ase chain reaction (PCR) and/or serum immunomon-
olayer peroxidase assay (IMPA) can be used to confirm 
the infection ante-mortem [1, 6, 9, 10]. Post-mortem the 
disease can be diagnosed by identifying L. intracellula-
ris with Warthin-Starry staining (WS), immunofluores-
cence (IF) or fluorescence in  situ hybridization (FISH) 
associated with proliferative lesions in the small intestine 
[11–15]. Treatment is by antimicrobials that achieve high 
intracellular concentrations [16], alongside supportive 
treatment with intravenous crystalloids, plasma or col-
loids [5].
EPE causes disease ranging from subclinical to acute 
and fatal [17–19]. The disease has been described as 
emerging in the North American horse population [20], 
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with larger outbreaks described in the United States [8] 
and Canada [4]. Additionally, single cases have been 
reported from Switzerland [21], England [22], Belgium 
[23], Israel [24], Brazil [25] and Australia [26]. In Den-
mark, a previous seroprevalence study showed that 5% 
of young horses admitted to a Danish referral hospital 
(University of Copenhagen Large Animal Teaching Hos-
pital) had measurable L. intracellularis serum antibodies 
[27]. However, this study was not linked to diagnosis or 
clinical signs. Since multiple porcine studies show a 100% 
specificity and no cross reactions with other pathogens 
for IMPA serology [28, 29], this seroprevalence study is 
strongly suggestive for Danish foals being exposed to the 
bacterium, although the test may act differently in foals 
compared to pigs. Reports of L. intracellularis infection 
in foals in Scandinavia is limited to a Swedish fecal PCR 
study on 108 clinically healthy foals 4–8 months old from 
four breeding farms, reporting only negative results [30] 
and a single short proceeding abstract where L. intra-
cellularis was identified in post-mortem samples of two 
Danish foals [15].
Due to the lack of peer-reviewed reports of EPE in 
Scandinavia, the main objective of this study was to 
describe the clinical aspects of confirmed cases of L. 
intracellularis infection associated with EPE in a Danish 
referral population.
Case presentations
Between 2008–2016 a total of five cases of EPE were 
diagnosed during hospitalization (n = 3) or retrospec-
tively by IMPA on stored frozen serum samples and/or 
IF and FISH on formalin-fixed ileum samples (n = 2) at 
the University of Copenhagen Large Animal Teaching 
Hospital.
Cases were 6–7  months-old Danish Warmbloods and 
one Friesian horse, four colts and one filly, all from differ-
ent premises. Cases presented in October to January in 
2008 (n = 1), 2012 (n = 1), 2015 (n = 2) and 2016 (n = 1).
Mean duration of disease noted by the owner before 
admission was 3  days. Four cases had been treated by 
referring veterinarian with non-steroidal anti-inflam-
matory drugs (flunixin meglumine or meloxicam), and 
three with antimicrobials (sulfadiazine-trimethoprim or 
penicillin procaine) before admission. Two had received 
anthelmintics within 2 weeks prior to presentation (iver-
mectin or fenbendazole).
Confirmed cases all displayed clinical signs of lethargy, 
pyrexia, tachycardia and peripheral edema. A summary 
of clinical signs is presented in Table 1.
All cases presented with hypoalbuminemia, hypona-
tremia, hypomagnesemia, hypocalcemia, increased 
fibrinogen and variably increased serum amyloid A, 
as shown in Table  2. Hypoalbuminemia became more 
profound during hospitalization for all cases (10.0–
15.0 g/L). Four cases presented initially with normal leu-
kocyte counts, however, three developed leukocytosis 
during the course of disease (17.0–28.5 × 109 cells/L).
Three cases had feces sampled for L. intracellularis 
real time PCR (Laboklin Gmbh & Co, Bad Kissingen, 
Germany) within the first 48 h of admission, confirming 
EPE. For the other two cases testing for L. intracellularis 
was not performed during hospitalization. A summary 
of diagnostic tests performed for included cases is pre-
sented in Table 3.
Concurrent intestinal parasitism was present in all 
five cases with either strongyles (240–300 eggs per gram 
(EPG) or grossly present on necropsy) or Parascaris spp. 
(340 EPG). Three cases (case 1, 2 and 4) had a fecal cul-
ture for Salmonella spp. performed and one (case 2) had 
Clostridium difficile toxin A and B and Clostridium per-
fringens enterotoxin analyzed, but all were found nega-
tive. Peritoneal fluid was analyzed for four cases (case 1–3 
and 5). The sample was mildly inflammatory in case 5, for 
the others samples were within normal limits. Abdominal 
ultrasound (Fig. 1) was performed in four cases (case 1–3 
Table 1 Clinical signs, diagnostic tests, post-mortem 
findings and  outcome in  foals with  equine proliferative 
enteropathy (n = 5)
EPE equine proliferative enteropathy
a Eggs, larvae or adult parasites found in feces or in the intestinal wall
Parameter EPE positive (n = 5)
Clinical sign
 Lethargy 5/5 (100%)
 Anorexia 5/5 (100%)
 Poor body condition 4/5 (80%)
 Peripheral edema 5/5 (100%)
 Colic 3/5 (60%)
 Diarrhea 4/5 (80%)
 Pyrexia (> 38.3 °C) 5/5 (100%)
Diagnostic tests
 Intestinal  parasitisma
  Overall 5/5 (100%)
  Strongyles 4/5 (80%)
  Parascaris spp. 1/5 (20%)
 Abdominal ultrasound





  Increased wall thickness 3/3 (100%)
 Large intestine
  Colitis 2/3 (67%)
Outcome
 Survival 2/5 (40%)
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Table 2 History, clinical signs, laboratory values (at admission) and clinical pathology of foals with equine proliferative 
enteropathy (n = 5)
Italics text: value outside reference range
Parameter Unit Reference Mean ± SD Range Number
History
 Duration of disease before admission 
(days)
– 3 ± 2 1 to 7 5
Clinical signs
 Heart rate Bpm 28–44 58 ± 9 48 to 76 5
 Respiratory rate Rpm 12–24 18 ± 5 12 to 24 5
Complete blood count and biochemistry
 Packed cell volume L/L 0.32–0.50 0.41 ± 0.07 0.37 to 0.52 5
 Leukocyte count 109/L 5.45–12.65 11.51 ± 3.14 8.47 to 17.00 5
 Neutrophil count 109/L 2.26–7.22 6.13 ± 3.47 1.20 to 10.80 5
 Serum protein g/L 57.0–74.0. 30.1 ± 4.2 25.1 to 34.6 5
 Albumin g/L 28.0–40.0 15.8 ± 2.8 13.0 to 19.7 5
 Fibrinogen g/L 0.0–4.0 6.3 ± 2.2 4.2 to 10.6 5
 Serum amyloid A mg/L 0–30 943 ± 1366 108 to 3643 5
 Iron μmol/L 13.1–43.0 10.0 ± 3.4 4.0 to 12.8 5
 Gamma-glutamyl transferase U/L 4–19 6 ± 2 4 to 8 4
 Total bilirubin μmol/L 0.0–52.0 34.7 ± 8.2 22.7 to 41.9 5
 Creatinine μmol/L 30–130 102 ± 18 80 to 129 5
 Creatinine kinase U/L 0–348 267 ± 127 134 to 487 5
 Asparate transaminase U/L 228–366 168 ± 38 128 to 227 5
 Sodium mmol/L 136–142 122 ± 3 119 to 126 5
 Potassium mmol/L 2.6–5.0 3.1 ± 0.4 2.8 to 3.8 5
 Chloride mmol/L 99–109 98 ± 4 93 to 105 5
 Ionised calcium mmol/L 1.40–1.72 1.26 ± 0.08 1.14 to 1.34 5
 Total magnesium mmol/L 0.66–0.95 0.43 ± 0.08 0.29 to 0.52 5
 Lactate mmol/L 0.0–2.0 2.8 ± 2.0 0.7 to 6.2 5
 Glucose mmol/L 4.3–9.0 7.8 ± 2.4 6.5 to 11.3 5
 pH 7.32–7.55 7.32 ± 0.07 7.20 to 7.40 5
 Bicarbonate mmol/L 24.0–30.0 20.0 ± 1.5 18.0 to 22.0 4
 Base excess − 4.0–4.0 − 6.1 ± 0.9 − 7.1 to − 6.2 3
 Triglycerides mmol/L 0.1–0.9 0.7 ± 0.1 0.6 to 0.8 2
Peritoneal fluid
 Protein g/L 0.0–10.0 4.5 ± 7.8 0.0 to 18.0 4
 Total nucleated cell count 109/L 0.0–10.0 5.3 ± 6.2 0.2 to 14.2 3
Table 3 Diagnostic test results of foals diagnosed with equine proliferative enteropathy 2008–2016
Italics: confirmative of equine proliferative enteropathy
NS non-survival, S survival, rtPCR real time polymerase chain reaction, IMPA immunomonolayer peroxidase assay, WS Warthin-Starry staining, IF immunofluorescence, 
FISH fluorescence in situ hybridization, NP not performed
a Formalin-fixed ileum samples
Case Age 
(months)
Outcome Fecal rtPCR IMPA (admission) IMPA (8 weeks) WSa IFa FISHa
1 7 NS Positive 1:100 NP Negative Negative Negative
2 6 S Positive < 1:25 NP NP NP NP
3 6 S Positive 1:50 1:200 NP NP NP
4 7 NS NP 1:480 NP Negative Positive Negative
5 6 NS NP < 1:25 NP NP Positive Positive
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and 5) and showed increased small intestinal wall thick-
ness for all (0.5–0.9 cm; normal range 0.2–0.3 [31]).
All five cases were treated with nonsteroidal anti-
inflammatories (flunixin meglumine1 or meloxicam2), 
crystalloids (Ringer’s-acetate3or sodium chloride 0.9%4) 
and colloids (hetastarch 6%5 and equine plasma6). Par-
tial parenteral nutrition was provided with glucose 50%7 
or amino acids 11.4%8 for three foals (case 1–3). One 
surviving foal (case 3) initially received benzyl penicil-
lin9 and gentamicin10 but was changed to rifampin11 and 
clarithromycin12 when EPE was suspected on day 2. Due 
to poor response, the foal received oxytetracycline13 
from day 4. The other surviving foal (case 2) was treated 
with oxytetracycline (see Footnote 13). One non-sur-
viving foal received erythromycin14 and rifampin (see 
Footnote 11) (case 1), one received benzyl penicillin 
and metronidazole (case 5) and the last non-survivor 
did not receive antimicrobial treatment (case 4). Addi-
tionally, sucralfate15 omeprazole16 and oral electrolytes 
were given to four cases. Three cases showed signs of 
colic at several occasions and were administered meta-
mizole17 butorphanol18 and butylscopolamine19 Addi-
tionally, treatment with dexamethasone20 enoxaparin21 
glutamin22, neostigmine23 calcium gluconate24 lido-
cain25 and bicarbonate was provided. Three foals were 
given anthelmintics during hospital stay (moxidectin26 
and fenbendazole27) and one foal received anthelmintic 
treatment after discharge.
Three foals (case 1, 4 and 5) were euthanised after 
4–5 days of treatment, due to sudden deterioration and 
poor prognosis. Post-mortem examination of case 4 
showed severe generalized edema and grossly increased 
small intestinal wall thickness. Histopathology of the 
duodenum and jejunum showed muscular hypertro-
phy, and in the ileum a few mineralized foci and a 
crypt abscess was found, however samples had autol-
ytic changes and could not be fully evaluated. On ret-
rospective analysis of serum, the foal had an IMPA titer 
of 480 (normal range: < 60 [1, 6]) (National Veterinary 
Fig. 1 Ultrasound images obtained in a foal with confirmed Lawsonia intracellularis infection. a Cross sectional view of small intestines with 
increased wall thickness of 0.9 cm (asterisk). b Longitudinal view of a small intestinal wall with increased echogenicity and thickness (arrow)
1 Findyne 50 mg/mL, Intervet.
2 Metacam 20 mg/mL, Boehringer Ingelheim Vetmedica.
3 Ringer-acetat Fresenius Kabi, Fresenius Kabi.
4 Natriumklorid 9 mg/mL, Fresenius Kabi.
5 Voluven 60 mg/mL, Fresenius Kabi.
6 Hypermune Equine Plasma, Veterinary Immunogenics.
7 Glucos 500 mg/mL, Fresenius Kabi.
8 Vamin 18 g N/I elektrolytfri, Fresenius Kabi.
9 Benzyl penicillin 1.2 g, Panpharma.
10 Genta-Equine 100 mg/mL, Dechra.
11 Rimactan 300 mg, Sandoz.
12 Clarithromycin 500 mg, Orion Pharma.
13 Engemycin 100 mg/mL, Intervet.
14 Hexabotin 500 mg, Durascan.
15 Antepsin 1 g, Orion Pharma.
16 GastroGuard 370 mg/g, Merial.
17 Vetalgin 500 mg/mL, Intervet.
18 Torbugesic 10 mg/mL, Orion Pharma.
19 Buscopan 20 mg/mL, Boehringer Ingelheim.
20 Dexadreson 2 mg/mL, Intervet.
21 Klexane 100 mg/mL, Sanofi.
22 l-Glutamine, Scientec Nutrition.
23 Neostigmin 2.5 mg/mL, SAD.
24 Calciject 40, Norbrook.
25 Lidocain 20 mg/mL, Mylan.
26 Equest 18.9%, Orion Pharma Animal Health.
27 Panacur 18.5%, MSD Animal Health.
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Laboratory, Technical University of Denmark (NVL)) and 
was positive by IF on formalin-fixed samples of the ileum 
(NVL).
Gross pathology of case 5 showed cachexia, hypertro-
phy of the small intestinal mucosa and multiple encysted 
cyathostomins in the colon wall. Histopathology of small 
intestinal sections were unremarkable, but formalin-fixed 
samples from the ileum were positive for L. intracellula-
ris by IF and FISH.
Case 1 presented with additional symptoms to the clas-
sical signs of EPE, with a respiratory noise from moder-
ate airway edema at admission. This foal was diagnosed 
with EPE based on a positive fecal PCR and a serum 
IMPA titer of 100. On day 3 of hospitalization, this foal 
developed septic arthritis of the tarsocrural joint. On the 
4th day of treatment the foal’s general condition rapidly 
worsened with circulatory compromise and development 
of severe pulmonary edema. Due to poor response to 
treatment, the foal was euthanised. Post-mortem exami-
nation showed gross generalized edema and increased 
small intestinal wall thickness. Additionally, the foal had 
peritonitis and an arterial thrombus causing infarction 
of the pelvic flexure of the colon. In the ileocolic artery, 
there was evidence of chronic arteritis with aneurysms 
and thrombi containing Strongylus vulgaris larvae. Histo-
pathology showed generalized thickened small intestine 
with chronic ulcerative enteritis and lymphocytic hyper-
plasia. Testing for L. intracellularis by IF and FISH was 
negative for this case.
The two surviving foals (case 2 and 3) were hospital-
ized for 5 and 11 days, respectively. Case 3 had a re-visit 
8 weeks after discharge where it was found clinically nor-
mal except for poor body condition and mild exfoliative 
dermatitis of the cannon bones and ear tips. Abdominal 
ultrasound was normal, complete blood count and bio-
chemistry showed normal albumin (28.9 g/L) and leuko-
cytes (10.1 × 109 cells/L), and mildly increased fibrinogen 
level (5.1  g/L). Serology at this time point revealed an 
IMPA titer of 200 compared to the admission titer of 
50 (Laboklin Gmbh & Co). On follow-up 1  year later 
the owner reported the colt to be healthy with a normal 
body condition. Case 3 had follow-up examination 4 days 
after discharge, where ultrasound showed small intesti-
nal thickening to have decreased, and serum albumin to 
be low but stable (15.0 g/L). Approximately 2 years after 
discharge the owner was contacted by telephone and 
reported the colt to be healthy.
Comparing blood samples between surviving and 
non-surviving cases, these were not different regarding 
severity of leukocytosis, hypoproteinemia, hypoalbu-
minemia, fibrinogen or serum amyloid A values.
Discussion and conclusions
To the authors’ knowledge, this is the first peer-reviewed 
report describing the clinical aspects of foals with L. 
intracellularis associated EPE in Scandinavia. This study 
supports that L. intracellularis not only circulates and 
foals are in contact with the bacterium, but also causes 
clinical disease (EPE) in Denmark. Therefore, EPE 
should be considered a differential diagnosis in Danish 
weanlings.
Lawsonia intracellularis is present in the majority 
(94%) of Danish pig farms [32]. A screening for L. intra-
cellularis was performed on stored serum samples at the 
Large Animal Teaching Hospital, University of Copen-
hagen from horses admitted 2005–2008, regardless of 
health status and/or diagnosis. Five percent of horses 
between 0 days and 24 months of age had detectable anti-
bodies by IMPA [27]. It has been shown in experimental 
studies that porcine strains can cause disease in horses 
[13], however, equine strains cause more severe disease 
[33], and is genetically slightly different from the porcine 
strains [34]. In the confirmed EPE cases of this report, 
there was no known association with pigs, and no strain 
assessment was performed.
Compared to reports from the USA and Canada [4, 8], 
only few cases were found in this study and none of them 
occurred in outbreaks. Yet, the cases presented were 
all within the expected age group of around 6  months, 
and presented at the time of year when EPE is most fre-
quently reported in other studies (September-January) 
[1]. Confirmed cases showed the typical clinical signs 
associated with EPE with lethargy, anorexia, pyrexia, 
peripheral edema, colic and diarrhea [1, 17], and the typi-
cal clinicopathological findings of hypoalbuminemia and 
leukocytosis [1]. For cases where abdominal ultrasound 
was performed, marked thickening of the small intestinal 
wall was seen. This is reported a common finding in EPE 
cases, with reports of wall thickness of up to 1.0 cm [5, 
7, 8, 35]. However, in some cases abdominal ultrasound 
is normal despite confirmed EPE, whereby this technique 
cannot be used to rule out the disease [1, 17]. Abdominal 
ultrasound is an important diagnostic tool and should be 
performed in cases suspected of EPE.
Fecal real time PCR was used to diagnose EPE in three 
of the reported cases; the other cases described in the 
current study did not have fecal samples submitted. The 
fecal PCR assays have been evaluated in pigs, showing 
very high specificity in several studies (100%), whereby 
false positives are unlikely [36–38]. The reported sensitiv-
ity is lower, ranging from 71% (early), and 38% (later) in 
the course of disease [11]. In studies of equine weanlings, 
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including only cases with positive serology and clinical 
signs suggestive of EPE, 74–79% of fecal samples were 
positive on PCR [1, 6]. There is a greater chance of posi-
tive fecal PCR if cases are sampled early in the course of 
disease, and before treatment with antimicrobials [1]. 
Our positive cases were sampled the day after arrival and 
had only received trimethoprim-sulfadiazine and peni-
cillin procaine, i.e. antimicrobials without intracellular 
penetration.
An additional ante-mortem diagnostic method is serol-
ogy by IMPA. In this study two different laboratories 
performed the IMPA analyses, with results reported in 
different dilutions of 50 or 60. In previous studies, foals 
have been considered seroconverted when IMPA titers 
were ≥ 60 [1, 6], and higher titers have correlated with 
more severe disease [17]. Recently also an enzyme-linked 
immunosorbent assay test was validated for the detection 
of L. intracellularis antibodies in horses [9]. Serology in 
the current study was confirmative of EPE for three cases 
(titers 100–480). In one of these, the titer was below 60 
on admission, but was significantly increased when re-
measured 8 weeks later (50 compared to 200). The larg-
est study on EPE published had 80% of cases positive by 
IMPA, and explained negative results most likely being a 
result of too early sampling [1]. In an experimental study, 
antibodies by IMPA in weanling’s after challenge with L. 
intracellularis was first detected after 2–3  weeks [17]. 
This could potentially explain the low titers in two cases 
positive by real time PCR or IF and FISH (case 2 and 5), 
with short duration of disease before admission, where 
detectable antibodies may not yet have been produced.
In this study, three techniques for post-mortem identi-
fication of L. intracellularis on formalin-fixed ileum sam-
ples were used. Warthin-Starry staining yielded negative 
results in the three non-surviving cases that were posi-
tive by other ante-mortem (real time PCR or IMPA) or 
post-mortem tests (IF and FISH). All post-mortem tests 
rely on the presence of bacteria or bacterial antigen in 
the tissue, with IF and FISH considered more sensitive 
and specific compared to WS [11, 12]. Previous antimi-
crobial treatment could have affected the results, since it 
has been reported that infected foals stop shedding the 
organism within 4  days after treatment is initiated [39]. 
The one foal positive by fecal real time PCR and serum 
IMPA (case 1) but negative on post-mortem tests, had 
received antimicrobial treatment (erythromycin and 
rifampin) with a duration of 4  days before euthanasia, 
possibly explaining these negative post-mortem findings.
Diagnosis of EPE is furthermore complicated by con-
comitant diseases with similar clinical presentation that 
frequently occur in foals, especially intestinal parasit-
ism. This is well described in the literature [1, 3–5, 7, 
8], and is also a finding in the current study. This can 
account for underdiagnosing of EPE. Concurrent intes-
tinal parasitism with strongyles or Parascaris spp. was 
found in all cases, making parasitism one of the major 
differential diagnoses of EPE. It should be stressed that 
in the case of cyathostomiasis in foals within the age 
group 4–8 months, additional testing for EPE should be 
performed. It may be speculated that concurrent intes-
tinal parasitism could make the foal more susceptible 
to L. intracellularis infection. In one non-surviving 
EPE case in the current study, chronic arteritis of the 
ileocolic artery and thrombi associated with S. vulgaris 
was diagnosed at necropsy. This was likely an impor-
tant contributing factor to the deterioration and sub-
sequent euthanasia of this foal. In the literature, there 
is evidence of coagulation disturbances in the form of 
epistaxis and hematochezia [19] and infarction from 
arterial thrombi [1, 3, 8] associated with EPE. This 
has been reported in severely affected cases with sus-
picion of translocation of bacteria over the inflamed 
and infected intestinal mucosa, and subsequent sepsis 
[19]. In these cases, the formation of thrombi has been 
attributed to severe hypoproteinemia and depletion of 
coagulation factors, along with severe systemic inflam-
matory response syndrome (SIRS) due to sepsis. Our 
case had evidence of necrotizing enteritis on post-mor-
tem examination, and evidence of sepsis from a septic 
joint. To our knowledge, this is the first case presented 
with confirmed EPE and concurrent S. vulgaris associ-
ated thromboembolism. However, it cannot be com-
pletely ruled out that thrombi and deterioration was 
also caused by sepsis and SIRS.
Based on the severity of hematologic and biochemis-
try changes, it was not possible to distinguish survivor 
from non-survivors in the current case series. Survival 
was only 40% in the current study, a low number in com-
parison to the 93% previously reported in a study of 57 
EPE affected foals from the USA [1]. Survival may have 
been affected by the advanced state of disease on admis-
sion, the choice of antimicrobials (both surviving foals 
were treated with oxytetracycline, and non-survivors 
instead received penicillin, metronidazole, erythromycin, 
rifampin or no antimicrobials), or the coinciding patholo-
gies. Unfortunately, the low number of included foals 
prevented statistical analysis of risk factors. However, 
long term prognosis for survivals seemed favorable, with 
the two surviving foals reported to be healthy on follow-
up 1 and 2 years later.
Limitations of this study are mainly due to the par-
tially retrospective nature, including lack of some 
clinical and laboratory data and inconsistent diagnos-
tic testing. Testing all suspected cases by fecal PCR 
early in disease, and later by serum IMPA, would have 
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been preferable to establish diagnosis and optimize 
treatment.
In Denmark, L. intracellularis was confirmed to cause 
clinical disease (EPE) in five weanling foals. Concurrent 
intestinal parasitism, an important differential diagno-
sis, was present in all foals. Therefore, the possibility 
of EPE should be considered in foals that are presented 
with diarrhea, pyrexia and/or severe hypoalbuminemia 
in this country, even if a diagnosis of intestinal parasit-
ism has been made already. Presentation was similar as 
in other parts of the world, with good response of the 
survivors in long term.
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